William Hagmann - Hagmann, W. K. The discovery of taranabant, a selective cannabinoid-1 receptor inverse agonist for the treatment of obesity. Archiv Pharm. Chem. Life Sci

Version 1

      Publication Details (including relevant citation   information): Hagmann, W. K. The discovery of   taranabant, a selective cannabinoid-1 receptor inverse agonist   for the treatment of obesity. Archiv Pharm. Chem. Life Sci. 341,   405 (2008)

      Abstract: null

      Address (URL):